Viewing entries tagged
ProsVue

A New, Improved Ultrasensitive PSA Test: ProsVue

Comment

A New, Improved Ultrasensitive PSA Test: ProsVue

Bottom line:  Previously published studies of standard ultrasensitive PSA assays used after surgery have shown some utility for predicting future cancer relapse. Therefore it is likely that ProsVue, which is substantially more accurate than existing PSA technology, will ultimately prove to be a useful and accurate test for predicting which men are at risk for a cancer relapse and are most likely to benefit from radiation.

Comment